EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Assessing efficacy of ADCY10 inhibitors in cervical mucus

Justine Fischoeder, Jai G Marathe, Deborah J Anderson, Lonny R Levin iD, Jochen Buck iD, Carla Ritagliati iD

Molecular Human Reproduction · 11.04.2026 · 32 (2)

DOI: 10.1093/molehr/gaag035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Human Reproduction, online erschienen am 04.06.2026. Verfasst von Justine Fischoeder und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Weill Cornell Medicine, New York, NY, USA. Hauptthemen laut MEDLINE: Cervix Mucus, Adenylyl Cyclases, Adenylyl Cyclase Inhibitors. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Male Contraceptive Initiative, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Male fertility depends on sperm motility, which enables sperm to traverse the female reproductive tract to the site of fertilization. Soluble adenylyl cyclase (sAC) is a key regulator of sperm motility, defining it as a promising non-hormonal contraceptive target for women and men. To evaluate the efficacy of sAC inhibitors under conditions mimicking the female reproductive tract, we employed a capillary assay using cervical mucus isolated from humans or cows as well as methylcellulose, a viscoelastic liquid that simulates cervical mucus. Addition of a sAC inhibitor, either directly to semen, modeling an on-demand male contraceptive, or to the cervical mucus, approximating a female contraceptive, effectively blocked sperm migration. These studies provide proof-of-concept for the efficacy of sAC inhibitors under physiologically relevant conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cervix MucusAdenylyl CyclasesAdenylyl Cyclase InhibitorsHumansFemaleAnimalsCattleMaleSperm MotilitySpermatozoa

Stichwörter der Autor:innen

capillary assaycervical mucuscontraceptivefemale reproductive tracthuman spermsACviscoelasticity

Substanzen

Adenylyl CyclasesADCY10 protein, humanAdenylyl Cyclase Inhibitors

Autor:innen und Institutionen

  • Department of Pharmacology, Weill Cornell Medicine, New York, NY, USA.
  • Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.

ORCID-Profile: Lonny R Levin, Jochen Buck, Carla Ritagliati

Förderung

  • Male Contraceptive Initiative
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Fischoeder, J., Marathe, J. G., Anderson, D. J., Levin, L. R., Buck, J., & Ritagliati, C. (2026). Assessing efficacy of ADCY10 inhibitors in cervical mucus. Molecular Human Reproduction, 32(2). https://doi.org/10.1093/molehr/gaag035

Vancouver

Fischoeder J, Marathe JG, Anderson DJ, Levin LR, Buck J, Ritagliati C. Assessing efficacy of ADCY10 inhibitors in cervical mucus. Molecular Human Reproduction. 2026;32(2). doi:10.1093/molehr/gaag035

BibTeX
@article{Fischoeder2026,
  author = {Fischoeder, Justine and Marathe, Jai G and Anderson, Deborah J and Levin, Lonny R and Buck, Jochen and Ritagliati, Carla},
  title = {Assessing efficacy of ADCY10 inhibitors in cervical mucus},
  journal = {Molecular Human Reproduction},
  year = {2026},
  volume = {32},
  number = {2},
  doi = {10.1093/molehr/gaag035}
}
Kostenlos starten →